edetic acid has been researched along with deferoxamine in 176 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 90 (51.14) | 18.7374 |
| 1990's | 53 (30.11) | 18.2507 |
| 2000's | 17 (9.66) | 29.6817 |
| 2010's | 15 (8.52) | 24.3611 |
| 2020's | 1 (0.57) | 2.80 |
| Authors | Studies |
|---|---|
| Raymond, KN; Rodgers, SJ | 1 |
| Bernhardt, PV; Islam, M; Kalinowski, DS; Lovejoy, DB; Richardson, DR; Senaratne, D; Sharpe, PC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hašková, P; Hergeselová, T; Hrušková, K; Kovaříková, P; Liptáková, L; Mingas, P; Potůčková, E; Šimůnek, T; Vávrová, K | 1 |
| Pugsley, AP; Reeves, P | 1 |
| García-Ibañez, R; Torún, B; Viteri, FE | 1 |
| Anast, CS; Broadus, AE; Genel, M; Gertner, JM; Grey, M; Pearson, H | 1 |
| Hornbostel, H; Kaufmann, W; Siegenthaler, W | 1 |
| Dybing, E | 1 |
| Walker, MD; Williams, DR | 1 |
| Jones, MM; Pratt, TH | 1 |
| Beach, DC; Giroux, E | 1 |
| Davison, AJ; Moon, J; Stern, A; Wu, Q | 1 |
| Chin, J; Haile, DJ; Harford, JB; Klausner, RD; Rouault, TA; Tang, CK | 1 |
| Coote, JG; Davies, RL; Freer, JH; Gibbs, HA; Parton, R | 1 |
| Kalyanaraman, B; Mason, RP; Morehouse, KM | 1 |
| Chitambar, CR; Lundberg, JH | 1 |
| Aruoma, OI; Cecchini, R; Halliwell, B | 1 |
| Kim, CM; Tabor, E | 1 |
| Kawabata, T; Liu, M; Okada, S | 1 |
| Comelli, M; Lippe, G; Mavelli, I; Mazzilis, D; Sala, FD | 1 |
| Mitrovic, DR; Stankovic, A | 1 |
| Bach, MK; Bienkowski, MJ; Brashler, JR; Sanders, ME | 1 |
| Popper, HH; Woldrich, A | 1 |
| Czapski, G; Goldstein, S | 1 |
| Heinrich, HC; Lehmann, WD | 1 |
| Dickson, C; Stern, A | 1 |
| Fontecave, M; Gerez, C; Mansuy, D; Reichard, P | 1 |
| Hider, RC; Porter, JB; Singh, S | 1 |
| Glennon, JD; Senior, AT | 1 |
| Bartsch, H; Gelboin, HV; Lin, DX; Malaveille, C; Park, SS | 1 |
| Leake, DS; Rankin, SM | 1 |
| Aitken, RJ; Johnson, MH; Nasr-Esfahani, M | 1 |
| Hoeffel, JM; Huchon, GJ; Lipavsky, A; Montgomery, AB; Murray, JF | 1 |
| Kachel, DL; Martin, WJ | 1 |
| Aronovitch, J; Czapski, G; Godinger, D; Goldstein, S | 1 |
| Beyer, WF; Fridovich, I | 1 |
| Hamazaki, S; Li, JL; Midorikawa, O; Okada, S; Toyokuni, S | 1 |
| Frenkel, K; Tofigh, S | 1 |
| Davison, AJ; Gee, P | 1 |
| Cederbaum, AI; Puntarulo, S | 1 |
| Buettner, GR | 1 |
| Clark, I; Gutteridge, JM; Halliwell, B; Quinlan, GJ | 1 |
| Svoboda, P; Teisinger, J; Vyskocil, F | 1 |
| Bulger, WH; Kupfer, D; Nanni, FJ | 1 |
| Cederbaum, AI | 2 |
| Brown, JM; Bump, EA; Mitchell, JB; Samuni, A | 1 |
| Arceneaux, JE; Byers, BR; Evans, SL; Tolbert, C | 1 |
| Buck, M; Chart, H; Griffiths, E; Stevenson, P | 1 |
| Advani, SH; Basrur, VS; Chitnis, MP; Satyamoorthy, K | 1 |
| Al-Bayati, ZA; Stohs, SJ | 1 |
| Bandy, B; Davison, AJ | 1 |
| Hedlund, BE; Paller, MS | 1 |
| Grankvist, K; Henriksson, R | 1 |
| Arfors, KE; Carlin, G; Djursäter, R | 1 |
| Harel, S; Kanner, J | 1 |
| Baum, H; O'Connell, MJ; Peters, TJ; Ward, RJ | 1 |
| Ceccarelli-Stanzani, D; Masini, A; Trenti, T; Ventura, E | 2 |
| Chew, BP; Tanaka, TS; Tjoelker, LW | 1 |
| MacDonald, RA; MacSween, RN; Pechet, GS | 1 |
| Günther, R | 1 |
| Forsea, D; Gheorghiu, G | 1 |
| Wills, ED | 1 |
| Aaseth, J | 1 |
| van Oye, R | 1 |
| Berneis, K; Kofler, M | 1 |
| Berneis, K; Bollag, W; Kofler, M | 1 |
| Ghidoni, A; Pozza, G; Sanesi, E | 1 |
| Casassa, PM; Cavalleri, GL | 1 |
| Greenberg, MS; Keating, J; Rosen, B | 1 |
| Pergola, F | 1 |
| Bruns, W; Michaelis, D; Takác, A | 1 |
| Bondet, P; Moene, Y; Perrot, H; Thivolet, J | 2 |
| Mallein, R; Perrot, H; Sabater, P; Thivolet, J | 1 |
| Brückner, R; Hess, R; Keberle, H; Pericin, C; Tripod, J | 1 |
| Cerruti Mainardi, P; Massimo, L | 1 |
| Klimmer, OR | 1 |
| Wirth, W | 1 |
| Matthes, KJ | 1 |
| Brancato, G; Cardinale, A; De Simone, GF | 1 |
| Brown, EB; Waxman, HS | 1 |
| Greenman, DA; Tennant, GB | 1 |
| Bottai, F | 1 |
| Barry, M; Cartei, G | 1 |
| Chisolm, JJ | 1 |
| Burg, G | 1 |
| Morgan, EH | 1 |
| Sawyer, BC; Slater, TF | 1 |
| Robertson, WO | 1 |
| Harmuth-Hoene, AE; Ohrtmann, R; Vladár, M | 1 |
| Spandrio, L | 1 |
| Carlin, G; Djursäter, R | 1 |
| Kitchin, KT | 1 |
| Cederbaum, AI; Dicker, E | 1 |
| Gutteridge, JM; Quinlan, GJ; Wilkins, S | 1 |
| Cerny, EA; Lau, EH; Rahman, YE; Wright, BJ | 1 |
| Carnes, BA; Cerny, EA; Lau, EH; Rahman, YE | 1 |
| Crumbliss, AL; Monzyk, B | 1 |
| Grady, RW; Hershko, C; Link, G | 1 |
| Cramer, SM; Horváth, C; Nathanael, B | 1 |
| Dervan, PB; Hertzberg, RP | 1 |
| Cory, JG; Lasater, L; Sato, A | 1 |
| Andrien, JM; Delvaux, D; Fillet, G | 1 |
| Cabbat, FS; Heikkila, RE | 1 |
| Halstead, BW; Williams, DR | 1 |
| Brunner, M; Moeslinger, T; Spieckermann, PG | 1 |
| Bast, A; van Acker, SA; van Asbeck, BS; van der Vijgh, WJ; Voest, EE | 1 |
| Ahmed, N; Jiang, H; Mao, Y; Shi, X | 1 |
| Giardina, PJ; Grady, RW; Hilgartner, MW; Salbe, AD | 1 |
| Ashraf, M; Onodera, T; Takemura, G | 1 |
| Afanas'ev, IB; Kozlov, AB; Ostrachovitch, EA | 1 |
| Faulkner, KM; Fridovich, I; Stevens, RD | 1 |
| Aust, AE; Chao, CC | 1 |
| Aitken, RJ; Buckingham, DW; Harkiss, D | 1 |
| Dawson, SJ; De Matteis, F; Gibbs, AH | 1 |
| Chart, H; Rowe, B | 1 |
| Azorin, I; Bella, MC; Fornas, E; Iborra, FJ; Renau-Piqueras, J | 1 |
| Courtiere, A; Molard, F; Reybaud, J | 1 |
| Kakkar, P; Mehrotra, S; Viswanathan, PN | 1 |
| Dame, MK; Diaz, M; Stoolman, L; Varani, J | 1 |
| Hashmi, AN; Saleemuddin, M | 1 |
| Hata, Y; Hiraishi, H; Ivey, KJ; Kawabe, T; Ota, S; Terano, A | 1 |
| De Leo, T; Di Meo, S; Piro, MC; Venditti, P | 1 |
| Hider, RC; Tilbrook, GS | 1 |
| Bergeron, RJ; Brittenham, GM; Wiegand, J | 3 |
| Dayan, FE; Duke, SO; Faibis, V; Jacobs, JM; Jacobs, NJ | 1 |
| Anandasbapathy, S; Elihu, N; Frishman, WH | 1 |
| Hershko, C; Konijn, AM; Link, G | 1 |
| Goodner, AP; Jacobson, ES; Nyhus, KJ | 1 |
| Benderitter, M; Briot, F; Dalloz, F; Maupoil, V; Rochette, L; Vergely, C | 1 |
| Klebanov, GI; Lyubitsky, OB; Vasiljeva, OV | 1 |
| Ishii, K; Kitagaki, H; Mino, Y; Mori, T; Nagasawa, O; Sasaki, M; Yamada, K | 1 |
| Barry, OP; FitzGerald, GA; Ghiselli, A; Iuliano, L; Pasin, M; Praticó, D; Sabatino, G; Violi, F | 1 |
| Munday, R | 1 |
| Han, JA; Kim, KM; Kim, SS; Kim, YM; Lea, HZ; Yoo, YM | 1 |
| Armstrong, C; Lees, GJ; Leong, W | 1 |
| Cook, J | 1 |
| Bandy, B; Davison, AJ; Moon, J; Walter, PB | 1 |
| Hiraku, Y; Kawanishi, S; Kojima, N; Murata, M; Oikawa, S; Sakano, K | 1 |
| Bruchelt, G; Gerber, CE; Greilberger, J; Jürgens, G; Ledinski, G; Niethammer, D | 1 |
| Cunningham, S; Hillard, CJ; Kalivendi, SV; Kalyanaraman, B; Kotamraju, S; Shang, T | 1 |
| Davidsson, L; Fidler, MC; Hurrell, RF; Walczyk, T | 1 |
| ALBAHARY, C; GIRAUD, J; LABARBE, P; RENAULT, J | 1 |
| TUTIN, M | 1 |
| MIKOL, C; RENOUX, M | 1 |
| DUGDALE, AE; POWELL, LW | 1 |
| DE GROOT, EJ; VERHAEGEN, H; VERHAEGEN-DECLERCQ, ML | 1 |
| DANIEL, EE; IRWIN, J | 1 |
| Naus, J; Pospísil, P; Snyrychová, I | 1 |
| Anchordoquy, TJ; Molina, Md | 1 |
| Garg, S; Rose, AL; Waite, TD | 1 |
| Clarke, SE; Hollis, FJ; Maggs, JL; Naisbitt, DJ; Park, BK; Sanderson, JP | 1 |
| Durbin, PW | 1 |
| Chung, KT; Makena, PS; Pierce, SC; Sinclair, SE | 1 |
| Corbitt, M; Fulp, S; Gosnell, D; Jarrard, J; Kean, G; Manning, T; Phillips, D; Thomas, J; Thomas, K; Ware, R | 1 |
| Huang, Y; Jiang, S; Lin, L; Liu, X; Xia, Y; Xiong, L | 1 |
| Abuknesha, RA; Al-Azemi, A; Fielder, MD; Price, RG | 1 |
| Bernhardt, PV; Martínez, M; Rodríguez, C; Vazquez, M | 1 |
| Canistro, D; Ganini, D; Jang, J; Jiang, J; Kadiiska, MB; Mason, RP; Stadler, K | 1 |
| Kummel, AC; Liberman, A; Pohaku Mitchell, KK; Trogler, WC | 1 |
| Kontoghiorghes, GJ | 1 |
| Girardot, C; Peyton, BM; Sani, RK; Spycher, N; Stewart, BD | 1 |
| Aburjai, TA; Alkhalil, SM; Ikeda, R; Komatsu, H; Kuroda, N; Nakashima, K; Wada, M | 1 |
| Fedotcheva, NI; Mokhova, EN | 1 |
| Brechbiel, MW; Guérard, F; Lee, YS | 1 |
| Braud, A; Cornu, JY; Dépernet, C; Garnier, C; Lebeau, T; Lenoble, V | 1 |
| Ellwood, MJ; Luxem, KE; Strzepek, RF | 1 |
| Chung, WY; Fiordalisi, C; Kowdley, KV; Messner, DJ; Surrago, C | 1 |
| Crumbliss, AL; Harrington, JM; Mysore, MM | 1 |
| Espósito, BP; Kaneko, TM; Lombardo, M; Lourenço, FR | 1 |
10 review(s) available for edetic acid and deferoxamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Therapeutic chelating agents.
Topics: Chelating Agents; Deferoxamine; Dimercaprol; Edetic Acid; Humans; Metallothionein; Metals; Penicillamine; Poisoning; Unithiol | 1976 |
Clinical usefulness of iron chelating agents.
Topics: Chelating Agents; Deferoxamine; Dimercaprol; Edetic Acid; Hemochromatosis; Humans; Iron; Iron Chelating Agents; Pentetic Acid; Thalassemia; Transferrin | 1969 |
Treatment of acute iron poisoning.
Topics: Acidosis; Acute Disease; Bicarbonates; Deferoxamine; Diarrhea; Edetic Acid; Emetics; Humans; Infusions, Parenteral; Iron; Poisoning; Shock; Vomiting | 1971 |
Chelating agents in medicine.
Topics: Aluminum; Cadmium; Chelating Agents; Chromium; Copper; Deferoxamine; Dimercaprol; Edetic Acid; Environmental Pollutants; Humans; Iron; Mercury; Metals; Molybdenum; Penicillamine; Plutonium; Unithiol | 1982 |
Iron chelators for clinical use.
Topics: Biological Transport; Deferoxamine; Drug Delivery Systems; Edetic Acid; Ferric Compounds; Free Radical Scavengers; Humans; Iron; Iron Chelating Agents; Iron Overload; Ligands; Molecular Weight; Oxidation-Reduction; Pentetic Acid; Razoxane; Solubility; Structure-Activity Relationship; Tissue Distribution | 1998 |
Chelation therapy in cardiovascular disease: ethylenediaminetetraacetic acid, deferoxamine, and dexrazoxane.
Topics: Antibiotics, Antineoplastic; Cardiovascular Diseases; Chelating Agents; Chelation Therapy; Deferoxamine; Doxorubicin; Edetic Acid; Female; Humans; Iron; Razoxane | 1998 |
Iron chelators for thalassaemia.
Topics: Administration, Oral; Aza Compounds; Chelating Agents; Deferiprone; Deferoxamine; Edetic Acid; Humans; Iron; Iron Chelating Agents; Iron Overload; Long-Term Care; Pyridones; Thalassemia | 1998 |
[HEMOCHROMATOSIS].
Topics: Bloodletting; Deferoxamine; Diagnosis; Dimercaprol; Drug Therapy; Edetic Acid; Hemochromatosis; Humans; Pathology | 1964 |
Iron chelators in medicinal applications - chemical equilibrium considerations in pharmaceutical activity.
Topics: Acid-Base Equilibrium; Cations; Crown Ethers; Deferoxamine; Edetic Acid; Iron Chelating Agents; Pentetic Acid; Peptides; Siderophores | 2009 |
2 trial(s) available for edetic acid and deferoxamine
| Article | Year |
|---|---|
Results from a phase I clinical trial of HBED.
Topics: Adolescent; Adult; beta-Thalassemia; Chelating Agents; Deferoxamine; Edetic Acid; Female; Humans; Iron; Male; Transfusion Reaction | 1994 |
Iron absorption from fish sauce and soy sauce fortified with sodium iron EDTA.
Topics: Adult; Anemia, Iron-Deficiency; Biological Availability; Deferoxamine; Diet; Edetic Acid; Female; Ferric Compounds; Ferritins; Fish Oils; Food, Fortified; Glycine max; Humans; Intestinal Absorption; Iron Isotopes; Iron, Dietary; Nutritional Status; Phytic Acid | 2003 |
164 other study(ies) available for edetic acid and deferoxamine
| Article | Year |
|---|---|
Ferric ion sequestering agents. 11. Synthesis and kinetics of iron removal from transferrin of catechoyl derivatives of desferrioxamine B.
Topics: Deferoxamine; Iron; Kinetics; Transferrin | 1983 |
Dipyridyl thiosemicarbazone chelators with potent and selective antitumor activity form iron complexes with redox activity.
Topics: Antineoplastic Agents; Ascorbic Acid; Benzoates; Chemical Phenomena; Chemistry, Physical; Crystallography, X-Ray; DNA; Electrochemistry; Humans; Hydroxylation; Iron; Iron Chelating Agents; Magnetic Resonance Spectroscopy; Models, Molecular; Oxidation-Reduction; Plasmids; Pyridines; Spectrophotometry, Infrared; Structure-Activity Relationship; Thiosemicarbazones | 2006 |
Aroylhydrazone iron chelators: Tuning antioxidant and antiproliferative properties by hydrazide modifications.
Topics: Animals; Antineoplastic Agents; Antioxidants; Cell Line, Tumor; Drug Stability; Humans; Hydrazines; Hydrazones; Hydrophobic and Hydrophilic Interactions; Iron Chelating Agents; Rats; Structure-Activity Relationship | 2016 |
Characterization of group B colicin-resistant mutants of Escherichia coli K-12: colicin resistance and the role of enterochelin.
Topics: 2,2'-Dipyridyl; Bacterial Proteins; Cell Membrane; Citrates; Colicins; Deferoxamine; Drug Resistance, Microbial; Edetic Acid; Enterobactin; Escherichia coli; Genes; Molecular Weight; Mutation; Peptide Biosynthesis; Serine | 1976 |
Sodium iron NaFeEDTA as an iron fortification compound in Central America. Absorption studies.
Topics: Absorption; Adult; Aging; Ascorbic Acid; Central America; Child, Preschool; Deferoxamine; Edetic Acid; Food, Fortified; Hemoglobins; Humans; Iron; Iron Deficiencies; Male; Sodium; Structure-Activity Relationship | 1978 |
Impaired parathyroid response to induced hypocalcemia in thalassemia major.
Topics: Adolescent; Adult; Blood Transfusion; Child; Deferoxamine; Edetic Acid; Ferritins; Humans; Hypocalcemia; Iron; Parathyroid Glands; Parathyroid Hormone; Thalassemia | 1979 |
[Therapy of poisoning with heavy metals].
Topics: Aminolevulinic Acid; Cadmium Poisoning; Chromium; Deferoxamine; Dimercaprol; Edetic Acid; Ferrocyanides; Humans; Infusions, Parenteral; Iron; Lead Poisoning; Manganese Poisoning; Mercury Poisoning; Occupational Medicine; Penicillamine; Pentetic Acid; Thallium | 1975 |
Methyldopa binding to cells in culture.
Topics: Acetaminophen; Allopurinol; Animals; Ascorbic Acid; Carcinoma, Hepatocellular; Cells, Cultured; Deferoxamine; Dimethylnitrosamine; Edetic Acid; Furosemide; Glutathione; Liver Neoplasms; Maleates; Methyldopa; Neoplasms, Experimental; Protein Binding; Rats; Superoxide Dismutase; Time Factors; Xanthines | 1977 |
The chemical principles of chronotherapy as established from an in vitro model of circadian concentration rhythms.
Topics: Circadian Rhythm; Computers; Deferoxamine; Drug Administration Schedule; Edetic Acid; Ethanol; Humans; Iron; Models, Biological; Theobromine; Time Factors | 1975 |
Inhibition of lipid peroxidation promoted by iron(III) and ascorbate.
Topics: Animals; Antioxidants; Ascorbic Acid; Catalase; Cyclic N-Oxides; Deferoxamine; Edetic Acid; Iron; Kinetics; Lipid Peroxidation; Microsomes, Liver; Oxygen; Rats; Sodium-Potassium-Exchanging ATPase | 1992 |
Effects of ligands on reduction of oxygen by vanadium(IV) and vanadium(III).
Topics: Adenosine Triphosphate; Deferoxamine; Edetic Acid; Histidine; Hydrogen-Ion Concentration; Kinetics; Ligands; Oxidation-Reduction; Oxygen; Vanadium | 1992 |
Reciprocal control of RNA-binding and aconitase activity in the regulation of the iron-responsive element binding protein: role of the iron-sulfur cluster.
Topics: Aconitate Hydratase; Animals; Cell Line; Deferoxamine; Dithiothreitol; Edetic Acid; Heme; Humans; Iron; Iron-Regulatory Proteins; Iron-Sulfur Proteins; Kinetics; Leukemia, Erythroblastic, Acute; Mice; Recombinant Proteins; RNA-Binding Proteins | 1992 |
Outer-membrane protein and lipopolysaccharide variation in Pasteurella haemolytica serotype A1 under different growth conditions.
Topics: Aerobiosis; Anaerobiosis; Bacterial Outer Membrane Proteins; Cell Division; Conalbumin; Culture Media; Deferoxamine; Edetic Acid; Gene Expression Regulation, Bacterial; Iron; Lipopolysaccharides; Mannheimia haemolytica; Pasteurella Infections; Serotyping | 1992 |
An electron paramagnetic resonance study of the interactions between the adriamycin semiquinone, hydrogen peroxide, iron-chelators, and radical scavengers.
Topics: Chelating Agents; Deferoxamine; Doxorubicin; Edetic Acid; Electron Spin Resonance Spectroscopy; Free Radical Scavengers; Free Radicals; Hydrogen Peroxide; Iron; Kinetics; Pentetic Acid | 1991 |
Interaction of gallium nitrate with fludarabine and iron chelators: effects on the proliferation of human leukemic HL60 cells.
Topics: Antineoplastic Agents; Cell Division; Deferoxamine; Drug Synergism; Edetic Acid; Gallium; Humans; Iron; Iron Chelating Agents; Leukemia, Promyelocytic, Acute; Tumor Cells, Cultured; Vidarabine Phosphate | 1990 |
The action of hydrogen peroxide on the formation of thiobarbituric acid-reactive material from microsomes, liposomes or from DNA damaged by bleomycin or phenanthroline. Artefacts in the thiobarbituric acid test.
Topics: Animals; Ascorbic Acid; Bleomycin; Chlorides; Cytochrome P-450 Enzyme Inhibitors; Deferoxamine; DNA; DNA Damage; Edetic Acid; Ferric Compounds; Hydrogen Peroxide; Lipid Peroxidation; Liposomes; Male; Microsomes, Liver; Phenanthrolines; Rats; Thiobarbiturates | 1990 |
Inhibition of human hepatocellular carcinoma and hepatoblastoma cell lines by deferoxamine.
Topics: alpha-Fetoproteins; Carcinoma, Hepatocellular; Cell Survival; Deferoxamine; DNA, Viral; Edetic Acid; Ferric Compounds; Ferrous Compounds; Fibroblasts; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Liver Neoplasms; Tumor Cells, Cultured | 1991 |
Radical-promoting "free" iron level in the serum of rats treated with ferric nitrilotriacetate: comparison with other iron chelate complexes.
Topics: Animals; Deferoxamine; Edetic Acid; Ferric Compounds; Free Radicals; Iron; Iron Chelating Agents; Lipid Peroxidation; Male; Nitrilotriacetic Acid; Rats; Rats, Inbred Strains | 1991 |
The inactivation of mitochondrial F1 ATPase by H2O2 is mediated by iron ions not tightly bound in the protein.
Topics: Adenosine Triphosphate; Animals; Cattle; Chelating Agents; Deferoxamine; Edetic Acid; Hydrogen Peroxide; Iron; Mannitol; Mitochondria, Heart; Pentetic Acid; Proton-Translocating ATPases; Superoxide Dismutase | 1991 |
Aluminum salts stimulate luminol-enhanced chemiluminescence production by human neutrophils.
Topics: Alum Compounds; Aluminum; Aluminum Chloride; Aluminum Compounds; Azides; Chlorides; Cytochalasin B; Deferoxamine; Edetic Acid; Ferric Compounds; Humans; Luminescent Measurements; Luminol; Neutrophils; Pentetic Acid; Sodium Azide | 1991 |
Pitfalls in the quantitative estimation of the secretion of granule proteins by eosinophils.
Topics: Animals; Catalase; Centrifugation, Density Gradient; Cricetinae; Deferoxamine; Drug Interactions; Edetic Acid; Electrophoresis, Polyacrylamide Gel; Eosinophil Peroxidase; Eosinophil-Derived Neurotoxin; Eosinophils; Humans; In Vitro Techniques; Leukapheresis; Neurotoxins; Peroxidases; Radioimmunoassay; Reproducibility of Results; Ribonucleases; Superoxide Dismutase | 1991 |
Oxygen radical formation a probable mechanism for chromate toxicity.
Topics: Animals; Butylated Hydroxytoluene; Cell Survival; Cells, Cultured; Chromates; Deferoxamine; Dimethyl Sulfoxide; Dithiothreitol; Edetic Acid; Free Radicals; Glutathione; Lung; Oxygen; Superoxide Dismutase | 1991 |
A reinvestigation of the reaction of desferrioxamine with superoxide radicals. A pulse radiolysis study.
Topics: Deferoxamine; Edetic Acid; Free Radicals; Half-Life; Hydrogen-Ion Concentration; Kinetics; Pulse Radiolysis; Solutions; Spectrophotometry; Superoxides | 1990 |
Ferrioxamine and its hexadentate iron-chelating metabolites in human post-desferal urine studied by high-performance liquid chromatography and fast atom bombardment mass spectrometry.
Topics: Chromatography, High Pressure Liquid; Deferoxamine; Edetic Acid; Ferric Compounds; Gas Chromatography-Mass Spectrometry; Hemochromatosis; Humans; Iron; Iron Chelating Agents; Spectrophotometry, Atomic | 1990 |
Tetravalent vanadium mediated oxidation of low density lipoprotein.
Topics: 1-Propanol; Cations; Deferoxamine; Edetic Acid; Electrophoresis, Polyacrylamide Gel; Ethanol; Humans; Kinetics; Lipid Peroxidation; Lipoproteins, LDL; Oxidation-Reduction; Spectrometry, Fluorescence; Thiobarbiturates; Vanadium; Vanadium Compounds | 1990 |
Reduction of the Fe(III)-tyrosyl radical center of Escherichia coli ribonucleotide reductase by dithiothreitol.
Topics: Anaerobiosis; Catalase; Cations, Divalent; Deferoxamine; Dithiothreitol; Edetic Acid; Enzyme Reactivators; Escherichia coli; Ferric Compounds; Ferrous Compounds; Hydrogen-Ion Concentration; Magnesium; Oxidation-Reduction; Ribonucleotide Reductases; Spectrophotometry; Superoxide Dismutase; Tyrosine | 1990 |
Separation and identification of desferrioxamine and its iron chelating metabolites by high-performance liquid chromatography and fast atom bombardment mass spectrometry: choice of complexing agent and application to biological fluids.
Topics: Adult; Aged; Binding, Competitive; Chromatography, High Pressure Liquid; Deferoxamine; Edetic Acid; Female; Humans; Iron Chelating Agents; Mass Spectrometry; Middle Aged; Protein Conformation; Sodium | 1990 |
Simultaneous determination of desferrioxamine and ferrioxamine by high-performance liquid chromatography with amperometric detection.
Topics: Chromatography, High Pressure Liquid; Citrates; Citric Acid; Deferoxamine; Edetic Acid; Ferric Compounds; Humans; Quality Control | 1990 |
Contribution of DNA methylation and benzylation to N-nitroso-N-benzyl-methylamine-induced mutagenesis in bacteria: effects of rat liver cytochrome P450 isozymes and glutathione transferases.
Topics: Animals; Antibodies, Monoclonal; Biotransformation; Carcinogens; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Deferoxamine; Dimethylnitrosamine; DNA, Bacterial; Edetic Acid; Esophagus; Ferric Compounds; Glutathione Transferase; Isoenzymes; Kinetics; Male; Methylation; Microsomes; Microsomes, Liver; Mucous Membrane; Mutagenicity Tests; Rats; Rats, Inbred F344; Rats, Inbred Strains; Salmonella typhimurium | 1990 |
The oxidative modification of low-density lipoproteins by macrophages.
Topics: Animals; Antioxidants; Blood; Copper; Culture Media; Deferoxamine; Edetic Acid; In Vitro Techniques; Iron; Lipoproteins, LDL; Macrophages; Mice; Oxidation-Reduction; Probucol; Time Factors | 1990 |
The effect of iron and iron chelators on the in-vitro block to development of the mouse preimplantation embryo: BAT6 a new medium for improved culture of mouse embryos in vitro.
Topics: Animals; Apoproteins; Ascorbic Acid; Cell Division; Culture Media; Culture Techniques; Deferoxamine; Dose-Response Relationship, Drug; Edetic Acid; Embryo, Mammalian; Embryonic Development; Female; Ferrous Compounds; Iron; Iron Chelating Agents; Mice; Pentetic Acid; Pregnancy; Transferrin | 1990 |
Respiratory clearance of aerosolized radioactive solutes of varying molecular weight.
Topics: Animals; Chromium Radioisotopes; Deferoxamine; Dextrans; Dogs; Edetic Acid; Gallium Radioisotopes; Indium; Lung; Pentetic Acid; Radionuclide Imaging; Sugar Acids; Technetium; Transferrin | 1987 |
Bleomycin-induced pulmonary endothelial cell injury: evidence for the role of iron-catalyzed toxic oxygen-derived species.
Topics: Animals; Bleomycin; Cattle; Cells, Cultured; Chromium Radioisotopes; Deferoxamine; Edetic Acid; Endothelium; Iron; L-Lactate Dehydrogenase; Oxygen; Pulmonary Artery; Superoxide Dismutase | 1987 |
Substitution reactions of iron-bleomycin-DNA with EDTA, detapac or desferrioxamine.
Topics: Bleomycin; Chelating Agents; Chemical Phenomena; Chemistry; Deferoxamine; DNA; DNA Damage; Edetic Acid; Pentetic Acid | 1987 |
Characterization of a superoxide dismutase mimic prepared from desferrioxamine and MnO2.
Topics: Ascorbic Acid; Cations; Chelating Agents; Chemical Phenomena; Chemistry; Deferoxamine; Edetic Acid; Manganese; Manganese Compounds; Oxidation-Reduction; Oxides; Spectrophotometry, Infrared; Spectrum Analysis; Superoxide Dismutase | 1989 |
Oxygen reduction and lipid peroxidation by iron chelates with special reference to ferric nitrilotriacetate.
Topics: Adenosine Diphosphate; Animals; Ascorbic Acid; Deferoxamine; Edetic Acid; Ferric Compounds; Iron Chelating Agents; Linoleic Acid; Linoleic Acids; Lipid Peroxidation; Liposomes; Membrane Lipids; Micelles; Microsomes, Liver; NADP; Nitrilotriacetic Acid; Oxidation-Reduction; Oxygen; Pentetic Acid; Rats; Rats, Inbred Strains | 1989 |
Effect of metals on nucleoside hydroperoxide, a product of ionizing radiation in DNA.
Topics: Chromatography, High Pressure Liquid; Copper; Deferoxamine; Deoxyuridine; DNA; Edetic Acid; Formates; Iron; Pentetic Acid; Thymidine | 1989 |
Intermediates in the aerobic autoxidation of 6-hydroxydopamine: relative importance under different reaction conditions.
Topics: Aerobiosis; Catalase; Chemical Phenomena; Chemistry; Deferoxamine; Edetic Acid; Formates; Free Radicals; Glucose; Hydrogen Peroxide; Hydroxides; Hydroxydopamines; Hydroxyl Radical; Mannitol; Metals; Oxidation-Reduction; Oxidopamine; Pentetic Acid; Superoxide Dismutase; Superoxides | 1989 |
Comparison of the ability of ferric complexes to catalyze microsomal chemiluminescence, lipid peroxidation, and hydroxyl radical generation.
Topics: Adenosine Diphosphate; Animals; Deferoxamine; Edetic Acid; Ferric Compounds; Hydroxides; Hydroxyl Radical; Lipid Peroxides; Luminescent Measurements; Male; Mannitol; Microsomes, Liver; NADP; NADPH-Ferrihemoprotein Reductase; Pentetic Acid; Rats; Rats, Inbred Strains | 1988 |
Ascorbate autoxidation in the presence of iron and copper chelates.
Topics: Ascorbic Acid; Cation Exchange Resins; Chelating Agents; Copper; Deferoxamine; Edetic Acid; Iron Chelating Agents; Oxidation-Reduction; Pentetic Acid; Resins, Synthetic; Superoxides | 1986 |
Aluminium salts accelerate peroxidation of membrane lipids stimulated by iron salts.
Topics: alpha-Linolenic Acid; Aluminum; Animals; Cations; Cattle; Deferoxamine; Edetic Acid; Erythrocyte Membrane; Ferrous Compounds; Humans; Hydrogen-Ion Concentration; Iron; Linolenic Acids; Lipid Peroxides; Liposomes; Membrane Lipids; Micelles; Pentetic Acid | 1985 |
Effect of catecholamines and metal chelating agents on the brain and brown adipose tissue Na,K-ATPase.
Topics: Adipose Tissue, Brown; Animals; Catecholamines; Cerebral Cortex; Chelating Agents; Deferoxamine; Edetic Acid; Egtazic Acid; Epinephrine; Isoproterenol; Kinetics; Microsomes; Norepinephrine; Rats; Rats, Inbred Strains; Sodium-Potassium-Exchanging ATPase; Stereoisomerism; Subcellular Fractions | 1986 |
Characteristics of the active oxygen in covalent binding of the pesticide methoxychlor to hepatic microsomal proteins.
Topics: Benzoates; Benzoic Acid; beta Carotene; Butanols; Carotenoids; Catalase; Deferoxamine; Edetic Acid; Ethanol; Histidine; Hydrogen Peroxide; Mannitol; Methoxychlor; Microsomes, Liver; NADP; Oxygen; Pentetic Acid; Proteins; Salicylates; Superoxide Dismutase; Superoxides; tert-Butyl Alcohol; Tryptophan; Zinc | 1986 |
Microsomal generation of hydroxyl radicals: its role in microsomal ethanol oxidizing system (MEOS) activity and requirement for iron.
Topics: Alcoholism; Animals; Deferoxamine; Edetic Acid; Ethanol; Free Radicals; Hydroxides; Hydroxyl Radical; Iron; Kinetics; Microsomes, Liver; Mixed Function Oxygenases; NADPH-Ferrihemoprotein Reductase; Oxidation-Reduction; Rats | 1987 |
Enhancement of misonidazole cytotoxicity by iron.
Topics: Animals; Cell Line; Cell Survival; Cricetinae; Cricetulus; Deferoxamine; Edetic Acid; Ferric Compounds; Iron; Misonidazole; Oxygen | 1986 |
Enhanced toxicity of copper for Streptococcus mutans under anaerobic conditions.
Topics: Anaerobiosis; Copper; Deferoxamine; Edetic Acid; Ferrozine; Phenanthrolines; Serotyping; Streptococcus mutans | 1986 |
Iron regulated outer membrane proteins of Escherichia coli: variations in expression due to the chelator used to restrict the availability of iron.
Topics: 2,2'-Dipyridyl; Autoradiography; Bacterial Outer Membrane Proteins; Chelating Agents; Conalbumin; Deferoxamine; Edetic Acid; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Iron | 1986 |
Potentiation of hydroxyurea cytotoxicity in human chronic myeloid leukemia cells by iron-chelating agent.
Topics: 2,2'-Dipyridyl; Antineoplastic Combined Chemotherapy Protocols; Deferoxamine; Drug Synergism; Edetic Acid; Humans; Hydroxybenzoates; Hydroxyurea; In Vitro Techniques; Leukemia, Myeloid; Pyridines | 1986 |
The role of iron in 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced lipid peroxidation by rat liver microsomes.
Topics: Adenosine Diphosphate; Administration, Oral; Animals; Chelating Agents; Deferoxamine; Dioxins; Drug Interactions; Edetic Acid; Female; Free Radicals; Iron; Lipid Peroxides; Microsomes, Liver; Polychlorinated Dibenzodioxins; Rats; Rats, Inbred Strains | 1987 |
Interactions between metals, ligands, and oxygen in the autoxidation of 6-hydroxydopamine: mechanisms by which metal chelation enhances inhibition by superoxide dismutase.
Topics: Adenosine Diphosphate; Catalase; Chelating Agents; Deferoxamine; Edetic Acid; Histidine; Hydrogen-Ion Concentration; Hydroxydopamines; Ligands; Metals; Oxidation-Reduction; Oxidopamine; Oxygen; Phytic Acid; Superoxide Dismutase | 1987 |
Role of iron in postischemic renal injury in the rat.
Topics: Animals; Deferoxamine; Edetic Acid; Free Radicals; Glomerular Filtration Rate; Iron; Ischemia; Kidney; Lipid Peroxidation; Male; Rats; Rats, Inbred Strains; Reperfusion | 1988 |
Protective effect of iron chelators on epirubicin-induced fibroblast toxicity.
Topics: Animals; Cell Line; Cell Survival; Deferoxamine; Drug Evaluation, Preclinical; Drug Interactions; Edetic Acid; Epirubicin; Fibroblasts; Iron Chelating Agents; Pentetic Acid | 1988 |
Inhibition of heme-promoted enzymatic lipid peroxidation by desferrioxamine and EDTA.
Topics: Animals; Catalase; Cattle; Deferoxamine; Edetic Acid; Heme; Hemin; Lipid Peroxidation; Methemoglobin; Oxyhemoglobins; Xanthine Oxidase | 1988 |
Desferrioxamine as an electron donor. Inhibition of membranal lipid peroxidation initiated by H2O2-activated metmyoglobin and other peroxidizing systems.
Topics: Cell Membrane; Copper; Deferoxamine; Edetic Acid; Electrons; Hemeproteins; Horseradish Peroxidase; Hydrogen Peroxide; Iron; Lipid Peroxidation; Metmyoglobin | 1987 |
The role of iron in ferritin- and haemosiderin-mediated lipid peroxidation in liposomes.
Topics: Deferoxamine; Edetic Acid; Ferritins; Hemosiderin; Hydrogen-Ion Concentration; Iron; Lipid Metabolism; Lipid Peroxides; Liposomes | 1985 |
The effect of ferric iron complex on isolated rat liver mitochondria. I. Respiratory and electrochemical responses.
Topics: Animals; Butylated Hydroxytoluene; Chromans; Deferoxamine; Dose-Response Relationship, Drug; Edetic Acid; Electrochemistry; Energy Metabolism; Ferric Compounds; Iron; Malondialdehyde; Membrane Potentials; Mitochondria, Liver; Oligomycins; Oxygen Consumption; Rats | 1985 |
The effect of ferric iron complex on isolated rat liver mitochondria. II. Ion movements.
Topics: Animals; Calcium; Chromans; Deferoxamine; Edetic Acid; Ferric Compounds; Iron; Magnesium; Membrane Potentials; Mitochondria, Liver; Oligomycins; Potassium; Rats; Succinates; Succinic Acid | 1985 |
In vitro growth inhibition of mastitis causing bacteria by phenolics and metal chelators.
Topics: Animals; Butylated Hydroxyanisole; Butylated Hydroxytoluene; Cattle; Chelating Agents; Deferoxamine; Edetic Acid; Escherichia coli; Ethylenediamines; Female; Hydroquinones; In Vitro Techniques; Klebsiella pneumoniae; Mastitis, Bovine; Pentetic Acid; Phenols; Staphylococcus aureus; Streptococcus agalactiae | 1985 |
Chelating agents in medicine.
Topics: Chelating Agents; Chemistry, Pharmaceutical; Deferoxamine; Dicumarol; Edetic Acid; Hemochromatosis; Hepatolenticular Degeneration; Humans; Lead Poisoning; Penicillamine | 1971 |
Iron metabolism by reticuloendothelial cells in vitro. Physical and chemical conditions, lipotrope deficiency, and acute inflammation.
Topics: Animals; Ascorbic Acid; Cobalt; Copper; Cysteine; Dactinomycin; Deferoxamine; Dinitrophenols; Edetic Acid; Fatty Liver; Fluorides; Fructose; Glucose; Glutathione; Hemochromatosis; Inflammation; Iodoacetates; Iron; Lipotropic Agents; Liver Cirrhosis; Lung; Macrophages; Microscopy, Electron; Potassium Permanganate; Protein Biosynthesis; Puromycin; Rabbits; RNA; Saponins; Sucrose; Surface-Active Agents; Transferrin; Trypsin | 1969 |
[Influence of chelating agents on the distribution and excretion of radioiron in rats].
Topics: Animals; Bone and Bones; Chelating Agents; Deferoxamine; Edetic Acid; Feces; Iron; Iron Isotopes; Kidney; Liver; Male; Muscles; Rats; Spleen | 1969 |
[Treatment of cutaneous porphyrias].
Topics: Adrenocorticotropic Hormone; Anabolic Agents; Deferoxamine; Edetic Acid; Humans; Porphyrias; Skin Diseases; Vitamins | 1968 |
Lipid peroxide formation in microsomes. The role of non-haem iron.
Topics: Animals; Ascorbic Acid; Deferoxamine; Edetic Acid; In Vitro Techniques; Iron; Lipid Metabolism; Microsomes; NADP; Peroxides; Phenanthrolines; Rats; Sucrose | 1969 |
[Recent advance in the therapy of metal poisoning with complexing agents].
Topics: Arsenic Poisoning; Carbon Isotopes; Chelating Agents; Deferoxamine; Dimercaprol; Edetic Acid; Humans; Iron; Lead Poisoning; Mercury Poisoning; Metals; Penicillamine; Pentetic Acid; Poisoning | 1972 |
[Harmful effects of common drugs on the visual apparatus. The oligo-elements and chelating agents. B. Chelating agents].
Topics: Chelating Agents; Deferoxamine; Dimercaprol; Edetic Acid; Eye Diseases; Humans; Penicillamine; Vision Disorders | 1972 |
The degradation of deoxyribonucleic acid by L-cysteine and the promoting effect of metal chelating agents and of catalase.
Topics: Catalase; Cysteamine; Cysteine; Deferoxamine; DNA; Edetic Acid; Oxidation-Reduction; Viscosity | 1964 |
The influence of chelating agents on the prooxidative effect of a hydrogen peroxide producing methylhydrazine compound.
Topics: Chemical Phenomena; Chemistry; Deferoxamine; DNA; Edetic Acid; Hydrogen Peroxide; Iron; Viscosity | 1964 |
Effect of desferrioxamine methansulphonate (DFOM) on glucose uptake by rat epididymal adipose tissue.
Topics: Adipose Tissue; Animals; Deferoxamine; Diabetes Mellitus; Edetic Acid; Glucose; Hemochromatosis; In Vitro Techniques; Rats | 1966 |
[Clinical contribution to the therapy of siderochromatosis].
Topics: Adult; Blood Transfusion; Bloodletting; Deferoxamine; Diet Therapy; Edetic Acid; Female; Hemosiderosis; Humans; Male; Middle Aged; Pigmentation Disorders | 1966 |
Iron toxicity treated with deferoxamine.
Topics: Blood; Child, Preschool; Deferoxamine; Edetic Acid; Humans; In Vitro Techniques; Iron; Kidney Function Tests; Liver Function Tests; Male; Pentetic Acid; Stomach; Urine | 1966 |
[Idiopathic hemochromatosis. Therapeutics].
Topics: Alcoholism; Bloodletting; Chelating Agents; Deferoxamine; Edetic Acid; Hemochromatosis; Humans; Liver Cirrhosis | 1967 |
[The diagnostic value of the desferrioxamine B test in the latent form of primary idiopathic hemochromatosis].
Topics: Adolescent; Adult; Child; Deferoxamine; Edetic Acid; Female; Hemochromatosis; Humans; Iron; Male; Middle Aged; Siderosis | 1966 |
[Treatment of late cutaneous porphyrias with iron chelating agents (EDTA, Desferral)].
Topics: Adult; Deferoxamine; Edetic Acid; Humans; Male; Middle Aged; Porphyrias; Skin Diseases | 1967 |
[Clinical and biological effects of chelating agents in porphyria cutanea tarda].
Topics: Adult; Aged; Deferoxamine; Edetic Acid; Feces; Humans; Male; Middle Aged; Porphyrias; Porphyrins | 1968 |
[Pathologic lens changes in experimental animals following continuous administration of high doses of Desferal].
Topics: Animals; Cataract; Cats; Deferoxamine; Dogs; Edetic Acid; Female; Galactose; Lens, Crystalline; Male; Rats | 1967 |
[Nosological classification and new therapeutic trends in idiopathic pulmonary hemosiderosis].
Topics: Adrenal Cortex Hormones; Azathioprine; Blood Protein Electrophoresis; Child, Preschool; Deferoxamine; Edetic Acid; Female; Hemosiderosis; Humans; Immunoelectrophoresis; Lung Diseases; Splenectomy | 1966 |
[Heavy metal antidotes].
Topics: Antidotes; Chelating Agents; Deferoxamine; Dimercaprol; Edetic Acid; Penicillamine; Pentetic Acid; Thallium; Thiocarbamates | 1968 |
[Possible side-effects of antidotal therapy].
Topics: Antidotes; Atropine; Chelating Agents; Cyanides; Deferoxamine; Dimercaprol; Edetic Acid; Humans; Hydroxocobalamin; Metals; Nitrites; Penicillamine; Pentetic Acid; Phenols; Phosphates; Poisoning; Pralidoxime Compounds; Thiosulfates | 1968 |
[Treatment of porphyria cutanea tarda by iron chelators (EDTA, Desferral)].
Topics: Adult; Deferoxamine; Edetic Acid; Humans; Male; Middle Aged; Porphyrias | 1967 |
[Regulation of iron metabolism].
Topics: Anemia, Hypochromic; Animals; Deferoxamine; Edetic Acid; Humans; Intestinal Absorption; Intestinal Mucosa; Iron; Iron Isotopes; Liver Cirrhosis; Rats; Transferrin | 1967 |
[Elimination of radiomercury by the kidneys: effect of drugs with a competitive action with chlormerodrin-Hg203].
Topics: Animals; Chlormerodrin; Cysteamine; Cysteine; Deferoxamine; Dimercaprol; Edetic Acid; Kidney; Mercury Isotopes; Rabbits; Thioctic Acid | 1967 |
Determination of iron in solutions containing iron complexes.
Topics: Ascorbic Acid; Autoanalysis; Deferoxamine; Edetic Acid; Ferritins; Hemoglobins; Humans; Iron; Potassium Permanganate | 1969 |
[The effect of chelating compounds on rat dentin].
Topics: Animals; Chelating Agents; Deferoxamine; Dentin; Edetic Acid; In Vitro Techniques; Odontoblasts; Rats | 1969 |
[A case of acute poisoning caused by ferrous fumarate. (Anatomo-clinical, physiopathological and therapeutic findings)].
Topics: Acute Disease; Adult; Deferoxamine; Digestive System; Edetic Acid; Female; Fumarates; Gastric Lavage; Humans; Iron; Kidney; Lung; Mannitol; Pentetic Acid; Pregnancy | 1969 |
Poisoning due to heavy metals.
Topics: Arsenic Poisoning; Cadmium Poisoning; Chelating Agents; Child; Child, Preschool; Copper; Deferoxamine; Dimercaprol; Edetic Acid; Gold; Humans; Infant; Iron; Lead Poisoning; Mercury Poisoning; Metals; Paint; Penicillamine; Pica; Poisoning; Thallium | 1970 |
[Therapy of porphyrias].
Topics: Acute Disease; Adenine Nucleotides; Antimalarials; Bicarbonates; Bloodletting; Deferoxamine; Diet Therapy; Edetic Acid; Humans; Phospholipids; Porphyrias; Pyridoxal Phosphate; Radiation-Protective Agents; Renal Dialysis | 1971 |
A study of iron transfer from rabbit transferrin to reticulocytes using synthetic chelating agents.
Topics: Acetates; Animals; Arsenic; Ascorbic Acid; Biological Transport; Bone Marrow; Bone Marrow Cells; Cell Membrane; Chelating Agents; Citrates; Deferoxamine; Dialysis; Dinitrophenols; Edetic Acid; Erythrocytes; Female; Glutathione; Hemoglobins; Imines; Iron; Iron Chelating Agents; Iron Isotopes; Kinetics; Nitriles; Phenanthrolines; Pyridines; Rabbits; Reticulocytes; Rotenone; Sulfhydryl Reagents; Temperature; Transferrin | 1971 |
The stimulatory effects of carbon tetrachloride on peroxidative reactions in rat liver fractions in vitro. Inhibitory effects of free-radical scavengers and other agents.
Topics: Aldehydes; Aniline Compounds; Animals; Carbon Tetrachloride; Deferoxamine; Edetic Acid; Female; Gallic Acid; Glycols; In Vitro Techniques; Inosine; Lipid Metabolism; Liver; Malonates; Microsomes, Liver; Peroxides; Polyethylenes; Promethazine; Rats; Vitamin E | 1971 |
Iron(3)-exchange between transferrin and chelates in vitro.
Topics: Acetates; Apoproteins; Bicarbonates; Blood; Chelating Agents; Chemical Phenomena; Chemistry; Cyclohexanes; Deferoxamine; Dialysis; Edetic Acid; Electrophoresis, Paper; Ethers; Humans; Iron; Iron Chelating Agents; Iron Isotopes; Kinetics; Nitriles; Phenols; Spectrophotometry; Sulfonic Acids; Transferrin | 1970 |
[Methods of determination of iron in biological fluids].
Topics: Body Fluids; Colorimetry; Deferoxamine; Edetic Acid; Humans; Hydrogen-Ion Concentration; Iron; Methods; Protein Binding; Spectrophotometry; Transferrin | 1971 |
Xanthine oxidase induced depolymerization of hyaluronic acid in the presence of ferritin.
Topics: Animals; Cattle; Chemical Phenomena; Chemistry; Deferoxamine; Edetic Acid; Ferritins; Hyaluronic Acid; Hydroxides; Hydroxyl Radical; Superoxides; Viscosity; Xanthine Oxidase | 1984 |
Regulation of rat hepatic delta-aminolevulinic acid synthetase and heme oxygenase activities: evidence for control by heme and against mediation by prosthetic iron.
Topics: 5-Aminolevulinate Synthetase; Animals; Bilirubin; Cobalt; Deferoxamine; Dextrans; Edetic Acid; Heme; Heme Oxygenase (Decyclizing); Iron-Dextran Complex; Kinetics; Liver; Male; Mixed Function Oxygenases; Protoporphyrins; Rats | 1983 |
Inhibition of microsomal oxidation of alcohols and of hydroxyl-radical-scavenging agents by the iron-chelating agent desferrioxamine.
Topics: Alcohols; Aminopyrine; Animals; Benzoates; Benzoic Acid; Deferoxamine; Dimethyl Sulfoxide; Edetic Acid; Ferric Compounds; Hydroxides; Hydroxyl Radical; In Vitro Techniques; Male; Methionine; Microsomes, Liver; Oxidation-Reduction; Rats; Rats, Inbred Strains | 1983 |
Organic hydroperoxide-dependent oxidation of ethanol by microsomes: lack of a role for free hydroxyl radicals.
Topics: 1-Butanol; Animals; Butanols; Catalysis; Chemical Phenomena; Chemistry; Deferoxamine; Edetic Acid; Ethanol; Free Radicals; Hydroxides; Hydroxyl Radical; In Vitro Techniques; Male; Microsomes, Liver; Oxidation-Reduction; Peroxides; Rats; Rats, Inbred Strains | 1983 |
Mitomycin C-induced deoxyribose degradation inhibited by superoxide dismutase. A reaction involving iron, hydroxyl and semiquinone radicals.
Topics: Animals; Benzoquinones; Cattle; Deferoxamine; Deoxyribose; Edetic Acid; Humans; Hydroxides; Hydroxyl Radical; Iron; Mitomycin; Mitomycins; Pentetic Acid; Quinones; Superoxide Dismutase; Xanthine Oxidase | 1984 |
Improvement of iron removal from the reticuloendothelial system by liposome encapsulation of N,N'-bis[2-hydroxybenzyl]-ethylenediamine-N,N'-diacetic acid (HBED). Comparison with desferrioxamine.
Topics: Animals; Bile; Bile Canaliculi; Chelating Agents; Deferoxamine; Edetic Acid; Feces; Female; Iron; Kupffer Cells; Liposomes; Liver; Mice; Microscopy, Electron; Mononuclear Phagocyte System; Tissue Distribution | 1983 |
Enhanced iron removal from liver parenchymal cells in experimental iron overload: liposome encapsulation of HBED and phenobarbital administration.
Topics: Animals; Deferoxamine; Edetic Acid; Feces; Ferritins; Iron; Liposomes; Liver; Mice; Phenobarbital | 1983 |
Factors that influence siderophoremediated iron bioavailability: catalysis of interligand iron (III) transfer from ferrioxamine B to EDTA by hydroxamic acids.
Topics: Biological Availability; Deferoxamine; Edetic Acid; Ferric Compounds; Hydroxamic Acids; Iron; Mathematics | 1983 |
Development and evaluation of the improved iron chelating agents EHPG, HBED and their dimethyl esters.
Topics: Administration, Oral; Animals; Deferoxamine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Edetic Acid; Ethylenediamines; Female; Infusions, Parenteral; Iron Chelating Agents; Iron Radioisotopes; Rats; Rats, Inbred Strains; Transfusion Reaction | 1984 |
High-performance liquid chromatography of deferoxamine and ferrioxamine: interference by iron present in the chromatographic system.
Topics: Chromatography, High Pressure Liquid; Deferoxamine; Edetic Acid; Ferric Compounds; Iron; Spectrophotometry | 1984 |
Cleavage of DNA with methidiumpropyl-EDTA-iron(II): reaction conditions and product analyses.
Topics: Animals; Ascorbic Acid; Catalase; Cattle; Deferoxamine; Dithiothreitol; DNA; DNA, Superhelical; Edetic Acid; Metals; Plasmids; Spectrophotometry; Superoxide Dismutase | 1984 |
Effect of iron-chelating agents on inhibitors of ribonucleotide reductase.
Topics: Animals; Carcinoma, Ehrlich Tumor; Chelating Agents; Deferoxamine; Edetic Acid; Female; Guanazole; Hydroxyurea; Iron Chelating Agents; Mice; Mice, Inbred ICR; Oxyquinoline; Ribonucleotide Reductases | 1981 |
[The treatment of post-transfusional hemochromatosis with chelating agents].
Topics: Adult; Chelating Agents; Deferoxamine; Edetic Acid; Hemochromatosis; Humans; Male; Pentetic Acid; Transfusion Reaction | 1981 |
Inhibition of iron-stimulated catecholamine degradation by the iron-chelators DETAPAC and Desferal. Potentially useful laboratory agents.
Topics: Catecholamines; Deferoxamine; Drug Stability; Edetic Acid; Ferrous Compounds; Iron Chelating Agents; Oxidation-Reduction; Pentetic Acid | 1981 |
Spectrophotometric determination of dehydroascorbic acid in biological samples.
Topics: 3T3 Cells; Animals; Ascorbic Acid; Chromatography, High Pressure Liquid; Deferoxamine; Dehydroascorbic Acid; Edetic Acid; Fibroblasts; Humans; Indicators and Reagents; Lymphocytes; Mammals; Mice; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry | 1994 |
Comparison of different iron chelators as protective agents against acute doxorubicin-induced cardiotoxicity.
Topics: Animals; Atrial Function; Cyclic N-Oxides; Deferoxamine; Doxorubicin; Drug Evaluation, Preclinical; Edetic Acid; Heart; Heart Atria; Hydrogen Peroxide; In Vitro Techniques; Iron Chelating Agents; Male; Mice; Mice, Inbred BALB C; Myocardial Contraction; Pyridones; Razoxane | 1994 |
HPLC investigation on Ni(II)-mediated DNA damage in the presence of t-butyl hydroperoxide and glutathione.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Catalase; Cattle; Chromatography, High Pressure Liquid; Deferoxamine; Deoxyguanosine; DNA; DNA Damage; Edetic Acid; Ethanol; Glutathione; Hydrogen-Ion Concentration; Kinetics; Nickel; Peroxides; Reactive Oxygen Species; Superoxide Dismutase; tert-Butylhydroperoxide | 1995 |
Characterization of exogenous hydroxyl radical effects on myocardial function, metabolism and ultrastructure.
Topics: Adenosine Triphosphate; Animals; Catalase; Deferoxamine; Dose-Response Relationship, Drug; Edetic Acid; Heart; Hydrogen Peroxide; Hydroxyl Radical; In Vitro Techniques; Lipid Peroxidation; Male; Microscopy, Electron; Myocardium; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 1994 |
Mechanism of inhibitory effects of chelating drugs on lipid peroxidation in rat brain homogenates.
Topics: Adenosine Diphosphate; Anemia; Animals; Antioxidants; Brain; Deferoxamine; Edetic Acid; Electron Spin Resonance Spectroscopy; Free Radicals; Iron; Iron Chelating Agents; Lipid Peroxidation; Models, Chemical; Oxygen; Phenanthrolines; Rats; Rutin; Spectrophotometry | 1994 |
Characterization of Mn(III) complexes of linear and cyclic desferrioxamines as mimics of superoxide dismutase activity.
Topics: Catalysis; Deferoxamine; Drug Stability; Edetic Acid; Kinetics; Manganese; Mass Spectrometry; Organometallic Compounds; Potentiometry; Superoxide Dismutase; Superoxides | 1994 |
Effect of long-term removal of iron from asbestos by desferrioxamine B on subsequent mobilization by other chelators and induction of DNA single-strand breaks.
Topics: Asbestos, Amosite; Asbestos, Crocidolite; Citrates; Citric Acid; Deferoxamine; DNA Damage; DNA, Single-Stranded; Edetic Acid; Hydrogen-Ion Concentration; Iron; Iron Chelating Agents; Kinetics; Time Factors | 1994 |
Analysis of lipid peroxidation mechanisms in human spermatozoa.
Topics: Deferoxamine; Edetic Acid; Ferrous Compounds; Humans; In Vitro Techniques; Lipid Peroxidation; Male; Malondialdehyde; Reactive Oxygen Species; Spectrophotometry; Spermatozoa; Thiobarbiturates | 1993 |
Two pathways of iron-catalyzed oxidation of bilirubin: effect of desferrioxamine and trolox, and comparison with microsomal oxidation.
Topics: Animals; Bilirubin; Biliverdine; Chromans; Cytochrome P-450 Enzyme System; Deferoxamine; Edetic Acid; Enzyme Induction; Glutathione; Hydrogen Peroxide; Iron; Male; Microsomes, Liver; Oxidation-Reduction; Polybrominated Biphenyls; Rats | 1993 |
Iron restriction and the growth of Salmonella enteritidis.
Topics: Bacterial Outer Membrane Proteins; Chelating Agents; Conalbumin; Deferoxamine; Edetic Acid; Eggs; Iron; Salmonella enteritidis | 1993 |
Effect of tert-butyl hydroperoxide addition on spontaneous chemiluminescence in brain.
Topics: Animals; Antioxidants; Ascorbic Acid; Brain; Deferoxamine; Edetic Acid; Female; Histocytochemistry; Iron; Lipid Peroxidation; Luminescent Measurements; Malondialdehyde; NADPH-Ferrihemoprotein Reductase; Peroxides; Rats; Rats, Wistar; tert-Butylhydroperoxide; Thiobarbituric Acid Reactive Substances | 1995 |
Differential effects of in vitro peroxidation on peripheral- and central-type benzodiazepine receptors. Protection by diverse antioxidants.
Topics: Animals; Antioxidants; Ascorbic Acid; Benzodiazepinones; Brain; Cell Membrane; Chromans; Deferoxamine; Edetic Acid; Ferrous Compounds; Flunitrazepam; Hypolipidemic Agents; Lipid Peroxidation; Liver; Malondialdehyde; Receptors, GABA-A; Rutin; Vitamin E | 1995 |
tBHP induced in vitro swelling of rat liver mitochondria.
Topics: Animals; Antipain; Deferoxamine; Dibucaine; Edetic Acid; Egtazic Acid; Kinetics; Leupeptins; Male; Mitochondria, Liver; Mitochondrial Swelling; Peroxides; Phospholipases A; Phospholipases A2; Protease Inhibitors; Rats; Rats, Wistar; Reactive Oxygen Species; Spermine; tert-Butylhydroperoxide | 1996 |
Deferoxamine interferes with adhesive functions of activated human neutrophils.
Topics: Adult; Animals; Cell Adhesion; Cell Line; Chelating Agents; Deferoxamine; Edetic Acid; Egtazic Acid; Endothelium, Vascular; Epithelium; Humans; Hydroxyethyl Starch Derivatives; In Vitro Techniques; Leukocyte Elastase; Lung; Metalloendopeptidases; Neutrophil Activation; Neutrophils; Pancreatic Elastase; Phenanthrolines; Rats; Tetradecanoylphorbol Acetate | 1996 |
Phenylhydrazine causes sulfhydryl oxidation and protein aggregation in hemoglobin-free human erythrocyte membranes.
Topics: Antioxidants; Blood Proteins; Catalase; Deferoxamine; Disulfides; Edetic Acid; Electrophoresis, Polyacrylamide Gel; Erythrocyte Membrane; Hemoglobins; Humans; Oxidation-Reduction; Phenylhydrazines; Sulfhydryl Compounds; Superoxide Dismutase | 1996 |
Hydrogen peroxide-mediated cytotoxicity to cultured colonic epithelial cells.
Topics: Animals; Catalase; Cell Survival; Cells, Cultured; Colon; Deferoxamine; Edetic Acid; Ferrous Compounds; Free Radicals; Hydrogen Peroxide; Intestinal Mucosa; Male; Oxidants; Rabbits; Reactive Oxygen Species; Superoxide Dismutase; Xanthine Oxidase | 1997 |
Enhanced luminescence study of liver homogenate response to oxidative stress.
Topics: Animals; Borates; Cytochrome c Group; Deferoxamine; Edetic Acid; Ferrous Compounds; Free Radical Scavengers; Hydroxyl Radical; Liver; Luminescent Measurements; Luminol; Oxidative Stress; Peroxidase; Peroxides; Photometry; Rats; Rats, Wistar; tert-Butylhydroperoxide | 1995 |
HBED: A potential alternative to deferoxamine for iron-chelating therapy.
Topics: Animals; Antidotes; Chelating Agents; Deferoxamine; Edetic Acid; Haplorhini; Iron Overload; Male; Rats; Rats, Sprague-Dawley; Transfusion Reaction | 1998 |
Horseradish peroxidase-dependent oxidation of deuteroporphyrin IX into chlorins.
Topics: Ascorbic Acid; Catalase; Deferoxamine; Deuteroporphyrins; Edetic Acid; Glutathione; Horseradish Peroxidase; Hydrogen Peroxide; Hydrogen-Ion Concentration; Kinetics; Oxidation-Reduction; Oxygen; Photosensitizing Agents; Porphyrins; Spectrophotometry, Ultraviolet; Sulfhydryl Compounds | 1998 |
Ferrous iron uptake in Cryptococcus neoformans.
Topics: Biological Transport; Chlorides; Copper; Cryptococcus neoformans; Deferoxamine; Edetic Acid; Ferric Compounds; Ferrous Compounds; Iron Radioisotopes; Kinetics | 1998 |
Studies by electron paramagnetic resonance of the importance of iron in the hydroxyl scavenging properties of ascorbic acid in plasma: effects of iron chelators.
Topics: Animals; Apoproteins; Ascorbic Acid; Deferoxamine; Edetic Acid; Electron Spin Resonance Spectroscopy; Ferrous Compounds; Free Radical Scavengers; Hydroxyl Radical; Iron; Iron Chelating Agents; Male; Rats; Rats, Wistar; Transferrin | 1998 |
HBED: the continuing development of a potential alternative to deferoxamine for iron-chelating therapy.
Topics: Administration, Oral; Animals; Cebus; Deferoxamine; Edetic Acid; Injections, Intravenous; Injections, Subcutaneous; Iron; Iron Chelating Agents; Iron Overload; Iron-Dextran Complex; Male; Rats; Rats, Sprague-Dawley | 1999 |
Effect of antioxidants on the kinetics of chain lipid peroxidation in liposomes.
Topics: Animals; Antioxidants; Ascorbic Acid; beta Carotene; Chick Embryo; Deferoxamine; Edetic Acid; Kinetics; Lipid Peroxidation; Liposomes; Luminescent Measurements; Rutin; Vitamin E | 1998 |
Characterization of Fe(III)-deferoxamine and Mn(II)-pectin as magnetic resonance imaging contrast agents.
Topics: Chelating Agents; Contrast Media; Deferoxamine; Edetic Acid; Magnetic Resonance Imaging; Pectins; Pentetic Acid | 1998 |
Iron-dependent human platelet activation and hydroxyl radical formation: involvement of protein kinase C.
Topics: Adult; Aspirin; Blood Platelets; Catalase; Chelating Agents; Collagen; Deferoxamine; Deoxyribose; Diuretics, Osmotic; Dose-Response Relationship, Drug; Edetic Acid; Enzyme Inhibitors; Female; Humans; Hydroxyl Radical; Indoles; Iron; Isoquinolines; Male; Maleimides; Mannitol; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Kinase C; Sulfonamides; Thromboxane A2; Thromboxane B2 | 1999 |
Inhibition of 2,3-dimethyl-1,4-naphthohydroquinone auto-oxidation by copper and by superoxide dismutase.
Topics: Animals; Buffers; Catalase; Cattle; Chelating Agents; Copper; Deferoxamine; Edetic Acid; Hydroquinones; Iron; Oxidation-Reduction; Oxygen Consumption; Superoxide Dismutase | 1999 |
Hemoglobin toxicity in experimental bacterial peritonitis is due to production of reactive oxygen species.
Topics: Animals; Chelating Agents; Cyclic N-Oxides; Deferoxamine; Disease Models, Animal; Edetic Acid; Escherichia coli Infections; Hemin; Hemoglobins; Hydrogen Peroxide; Macrophages, Peritoneal; Male; Oxidative Stress; Pentetic Acid; Peritonitis; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Superoxide Dismutase; Superoxides | 1999 |
Comparative effects of metal chelating agents on the neuronal cytotoxicity induced by copper (Cu+2), iron (Fe+3) and zinc in the hippocampus.
Topics: Animals; Cell Survival; Chelating Agents; Chlorides; Copper Sulfate; Cytotoxins; Deferoxamine; Edetic Acid; Ethylenediamines; Ferric Compounds; Hippocampus; Male; Neurons; Phenanthrolines; Rats; Rats, Wistar; Zinc | 2001 |
Radiation sensitization of mammalian cells by metal chelators.
Topics: Animals; Cell Cycle; Chelating Agents; Colony-Forming Units Assay; Cricetinae; Cricetulus; Deferiprone; Deferoxamine; DNA Replication; Edetic Acid; Fibroblasts; Genes, p53; Humans; Iron Chelating Agents; Lung; Lung Neoplasms; Mimosine; Pyridones; Radiation-Sensitizing Agents; S Phase; Tumor Cells, Cultured | 2001 |
Reaction of oxygen with 6-hydroxydopamine catalyzed by Cu, Fe, Mn, and V complexes: identification of a thermodynamic window for effective metal catalysis.
Topics: Adenosine Diphosphate; Bromides; Buffers; Catalysis; Copper; Deferoxamine; Edetic Acid; Histidine; Hydrogen-Ion Concentration; Iron; Ligands; Manganese; Osmolar Concentration; Oxidation-Reduction; Oxidopamine; Oxygen; Phytic Acid; Sodium Compounds; Thermodynamics; Vanadium | 2001 |
Mechanism of metal-mediated DNA damage induced by metabolites of carcinogenic 2-nitropropane.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Carcinogens; Catalase; Chelating Agents; Deferoxamine; Deoxyguanosine; DNA; DNA Damage; Dose-Response Relationship, Drug; Edetic Acid; Free Radical Scavengers; Free Radicals; Humans; Hydroxylamines; Ions; Iron; Metals; Models, Chemical; Mutagens; Nitroparaffins; Oxygen; Propane | 2001 |
HBED ligand: preclinical studies of a potential alternative to deferoxamine for treatment of chronic iron overload and acute iron poisoning.
Topics: Acute Disease; Animals; Blood Pressure; Cebus; Chronic Disease; Deferoxamine; Disease Models, Animal; Dogs; Drug Administration Routes; Drug Evaluation, Preclinical; Edetic Acid; Heart Rate; Iron; Iron Chelating Agents; Iron Overload; Male; Poisoning; Rats; Rats, Sprague-Dawley; Therapeutic Equivalency | 2002 |
Low-density lipoprotein modification by normal, myeloperoxidase-deficient and NADPH oxidase-deficient granulocytes and the impact of redox active transition metal ions.
Topics: Adult; Deferoxamine; Edetic Acid; Female; Granulocytes; Humans; Lipoproteins, LDL; Male; NADPH Oxidases; Oxidation-Reduction; Pentetic Acid; Peroxidase; Phenanthrolines; Reference Values | 2002 |
1-Methyl-4-phenylpyridinium (MPP+)-induced apoptosis and mitochondrial oxidant generation: role of transferrin-receptor-dependent iron and hydrogen peroxide.
Topics: 1-Methyl-4-phenylpyridinium; Aconitate Hydratase; Animals; Antioxidants; Apoptosis; Caspase 3; Caspases; Cells, Cultured; Deferoxamine; Edetic Acid; Female; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Humans; Hydrogen Peroxide; Iron; Iron Chelating Agents; Male; Metalloporphyrins; Mitochondria; NADH, NADPH Oxidoreductases; Neurons; Oxidants; Oxidative Stress; Parkinson Disease; Reactive Oxygen Species; Receptors, Transferrin; Staining and Labeling; Transferrin | 2003 |
[The treatment of siderosis by desferrioxamine B. Comparison with the action of 2 other chelating agents].
Topics: Chelating Agents; Deferoxamine; Edetic Acid; Humans; Siderosis | 1962 |
[THE TREATMENT OF HEMOCHROMATOSIS].
Topics: Bloodletting; Chelating Agents; Deferoxamine; Diet; Diet Therapy; Dimercaprol; Edetic Acid; Hemochromatosis; Humans; Iron | 1964 |
[CHELATION].
Topics: Chelating Agents; Deferoxamine; Drug Therapy; Edetic Acid; Humans; Iron; Penicillamine; Pharmacology; Toxicology | 1964 |
ACUTE IRON POISONING: ITS EFFECTS AND TREATMENT.
Topics: Chelating Agents; Deferoxamine; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Edetic Acid; Heavy Metal Poisoning; Humans; Infant; Iron; Metals, Heavy; Pathology; Poisoning; Sulfates; Toxicology | 1964 |
ON THE MECHANISMS WHEREBY EDTA, EGTA, DPTA, OXALATE, DESFERRIOXAMINE, AND 1,10-PHENANTHROLINE AFFECT CONTRACTILITY OF RAT UTERUS.
Topics: Calcium; Chelating Agents; Deferoxamine; Edetic Acid; Egtazic Acid; Female; Humans; Magnesium; Muscle Contraction; Muscle, Smooth; Oxalates; Pharmacology; Phenanthrolines; Rats; Research; Sodium; Strontium; Uterus | 1965 |
The effect of metal chelators on the production of hydroxyl radicals in thylakoids.
Topics: Chelating Agents; Deferoxamine; Edetic Acid; Hydroxyl Radical; Light; Pentetic Acid; Pisum sativum; Thylakoids | 2006 |
Metal contaminants promote degradation of lipid/DNA complexes during lyophilization.
Topics: Animals; Chelating Agents; Chlorocebus aethiops; COS Cells; Deferoxamine; DNA; Edetic Acid; Ferric Compounds; Fluorescamine; Freeze Drying; Indicators and Reagents; Iron Chelating Agents; Liposomes; Pentetic Acid; Phenanthrolines; Reactive Oxygen Species; Solutions; Transfection; Trehalose; Water | 2007 |
Superoxide mediated reduction of organically complexed iron(III): comparison of non-dissociative and dissociative reduction pathways.
Topics: Benzenesulfonates; Benzopyrans; Citrates; Deferoxamine; Edetic Acid; Ferrozine; Hydroxybenzoates; Iron; Oxidation-Reduction; Salicylates; Siderophores; Superoxides | 2007 |
Nonenzymatic formation of a novel hydroxylated sulfamethoxazole derivative in human liver microsomes: implications for bioanalysis of sulfamethoxazole metabolites.
Topics: Ascorbic Acid; Chromatography, High Pressure Liquid; Deferoxamine; Edetic Acid; Enzyme Inhibitors; Ferrous Compounds; Humans; Hydrogen Peroxide; Hydroxylation; Kinetics; Microsomes, Liver; Molecular Structure; NADP; Sulfamethoxazole; Tandem Mass Spectrometry; Triazoles | 2008 |
Lauriston S. Taylor Lecture: the quest for therapeutic actinide chelators.
Topics: Actinoid Series Elements; Americium; Animals; Chelating Agents; Deferoxamine; Edetic Acid; Humans; Mice; Pentetic Acid; Phenols; Plutonium; Uranium | 2008 |
Comparative mutagenic effects of structurally similar flavonoids quercetin and taxifolin on tester strains Salmonella typhimurium TA102 and Escherichia coli WP-2 uvrA.
Topics: Animals; Antioxidants; Ascorbic Acid; Catalase; Deferoxamine; Edetic Acid; Escherichia coli; Iron; Iron Chelating Agents; Liver Extracts; Microbial Sensitivity Tests; Mutagenesis; Mutagenicity Tests; Mutation; NADP; Quercetin; Rats; Salmonella typhimurium; Superoxide Dismutase | 2009 |
A comparative study on the enhancement efficacy of specific and non-specific iron chelators for protoporphyrin IX production and photosensitization in HaCat cells.
Topics: Aminolevulinic Acid; Cell Line, Transformed; Deferoxamine; Edetic Acid; Humans; Iron Chelating Agents; Keratinocytes; Photosensitivity Disorders; Photosensitizing Agents; Protoporphyrins | 2009 |
Effects of chelating agent and environmental stresses on microbial biofilms: relevance to clinical microbiology.
Topics: Bacterial Toxins; Biofilms; Chelating Agents; Deferoxamine; Desiccation; Edetic Acid; Exotoxins; Hot Temperature; Hydrogen-Ion Concentration; Leukocidins; Staphylococcus aureus; Stress, Physiological | 2011 |
Biologically active thiosemicarbazone Fe chelators and their reactions with ferrioxamine B and ferric EDTA; a kinetic study.
Topics: Deferoxamine; Edetic Acid; Ferric Compounds; Iron; Iron Chelating Agents; Kinetics; Solutions; Stereoisomerism; Thiosemicarbazones | 2012 |
Ceruloplasmin (ferroxidase) oxidizes hydroxylamine probes: deceptive implications for free radical detection.
Topics: Animals; Artifacts; Biological Assay; Catalase; Ceruloplasmin; Chelating Agents; Deferoxamine; Edetic Acid; Free Radicals; Heparin; Humans; Hydroxylamines; Oxidants; Oxidation-Reduction; Pentetic Acid; Phenanthrolines; Rats; Superoxide Dismutase | 2012 |
Iron(III)-doped, silica nanoshells: a biodegradable form of silica.
Topics: Animals; Biocompatible Materials; Cattle; Deferiprone; Deferoxamine; Edetic Acid; Ferric Compounds; Humans; Iron Chelating Agents; Nanoshells; Pyridones; Serum; Silicon Dioxide; Transferrin | 2012 |
The proceedings of the 20th International Conference on Chelation held in the USA: advances on new and old chelation therapies.
Topics: Chelating Agents; Chelation Therapy; Deferiprone; Deferoxamine; Edetic Acid; Humans; Iron Overload; Metals; Poisoning; Pyridones; Risk Assessment; Thalassemia; Treatment Outcome; United States | 2013 |
Influence of chelating agents on biogenic uraninite reoxidation by Fe(III) (Hydr)oxides.
Topics: Chelating Agents; Chlorides; Deferoxamine; Edetic Acid; Ferric Compounds; Nitrilotriacetic Acid; Oxidation-Reduction; Shewanella putrefaciens; Uranium | 2013 |
In vitro screening of Fe2+-chelating effect by a Fenton's reaction-luminol chemiluminescence system.
Topics: Deferiprone; Deferoxamine; Edetic Acid; Ferrous Compounds; Iron Chelating Agents; Luminescence; Luminol; Molecular Structure; Phenanthrolines; Pyridones | 2014 |
Mitochondrial models of pathologies with oxidative stress. Efficiency of alkalization to reduce mitochondrial damage.
Topics: Animals; Deferoxamine; Edetic Acid; Ferric Compounds; Hydrogen-Ion Concentration; Male; Mitochondria, Liver; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Models, Biological; Oxidative Stress; Rats; Rats, Wistar; tert-Butylhydroperoxide | 2013 |
Rational design, synthesis, and evaluation of tetrahydroxamic acid chelators for stable complexation of zirconium(IV).
Topics: Chelating Agents; Coordination Complexes; Crystallography, X-Ray; Deferoxamine; Edetic Acid; Ferric Compounds; Hydroxamic Acids; Kinetics; Positron-Emission Tomography; Radioisotopes; Zirconium | 2014 |
How do low doses of desferrioxamine B and EDTA affect the phytoextraction of metals in sunflower?
Topics: Biodegradation, Environmental; Chelating Agents; Deferoxamine; Edetic Acid; Helianthus; Metals, Heavy; Soil Pollutants | 2017 |
Intraspecific variability in Phaeocystis antarctica's response to iron and light stress.
Topics: Acclimatization; Chlorophyll; Chlorophyll A; Colony Count, Microbial; Deferoxamine; Edetic Acid; Environment; Haptophyta; Iron; Light; Photosynthesis; Species Specificity; Stress, Physiological | 2017 |
Isolation and characterization of iron chelators from turmeric (Curcuma longa): selective metal binding by curcuminoids.
Topics: Aluminum; Animals; Binding, Competitive; Calcium; Cell Line; Chromatography, Affinity; Copper; Curcuma; Curcumin; Deferoxamine; Diarylheptanoids; Edetic Acid; Epithelial Cells; Ferric Compounds; Iron; Iron Chelating Agents; Kinetics; Liver; Magnesium; Manganese; Nitrilotriacetic Acid; Plant Extracts; Rats; Zinc | 2017 |
The kinetics of dimethylhydroxypyridinone interactions with iron(iii) and the catalysis of iron(iii) ligand exchange reactions: implications for bacterial iron transport and combination chelation therapies.
Topics: Bacteria; Catalysis; Chelation Therapy; Deferiprone; Deferoxamine; Edetic Acid; Ferric Compounds; Humans; Hydroxamic Acids; Ion Transport; Iron; Iron Chelating Agents; Iron Overload; Kinetics; Ligands; Pyridones | 2018 |
The application of pharmaceutical quality by design concepts to evaluate the antioxidant and antimicrobial properties of a preservative system including desferrioxamine.
Topics: Anti-Infective Agents; Antioxidants; Ascorbic Acid; Aspergillus; Candida albicans; Deferoxamine; Edetic Acid; Escherichia coli; Microbial Sensitivity Tests; Models, Theoretical; Parabens; Preservatives, Pharmaceutical; Pseudomonas aeruginosa; Staphylococcus aureus; Sulfites | 2020 |